发明名称 Non-natural MIC proteins
摘要 This invention describes soluble, monovalent, non-natural protein molecules that can activate NK cells and certain T-cells to attack specific cellular target cells by attaching the NKG2D-binding portions of monovalent MICA or MICB protein, i.e. their α1-α2 platform domain, to the intended target cell specifically. The α1-α2 domain is contiguous with a heterologous α3 domain that has been genetically modified to bind directly or indirectly to the extracellular aspect of the target cell, thereby serving as the targeting domain. The genetic modification to create a non-natural and non-terminal targeting motif within the α3 domain can include a portion of an antibody, another protein molecule or portion thereof, a peptide, or a non-natural, modified α3 domain of a MIC protein.
申请公布号 US9079969(B2) 申请公布日期 2015.07.14
申请号 US201414311130 申请日期 2014.06.20
申请人 AvidBiotics Corp. 发明人 Martin, Jr. David W.;Williams Steven R.
分类号 C07H21/02;C07H21/04;C07K14/47;C07K14/74;C07K14/00;A61K38/00 主分类号 C07H21/02
代理机构 Sughrue Mion, PLLC 代理人 Sughrue Mion, PLLC
主权项 1. A nucleic acid molecule encoding a non-natural, monomeric, soluble, mammalian MHC class I chain-related (MIC) molecule comprising an α1-α2 platform domain attached to a targeting motif, wherein the α1-α2 platform domain is at least 80% identical to a native α1-α2 platform domain of a MIC protein, and wherein the α1-α2 platform domain binds an NKG2D receptor, and wherein the targeting motif comprises a MIC α3 domain and one or more heterologous peptides, wherein the heterologous peptide or peptides are inserted into the MIC α3 domain within one or more sites in a solvent-exposed loop at a non-carboxy-terminal site, and wherein the heterologous peptide or peptides direct the binding of the targeting motif to one or more target molecules on one or more target cells, thereby delivering the attached α1-α2 platform domain to the target cell.
地址 San Francisco CA US